ReP USP - Resultado da busca

Artigo de periodico
Functional analysis of PCSK9 3'UTR variants and mRNA-miRNA interactions in patients with familial hypercholesterolemia (2021)
Los, Bruna ; Borges, Jéssica Bassani ; Oliveira, Victor Fernandes de ; Freitas, Renata Caroline Costa de ; Hernandez, Carolina Dagli ; Bortolin, Raul Hernandes ; Gonçalves, Rodrigo M ; Faludi, André Arpad ; Rodrigues, Alice Cristina ; Bastos, Gisele Medeiros ; Jannes, Cinthia Elim ; Pereira , Alexandre C ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Source: Epigenomics. Unidades: IDPC, ICB, FCF
Subjects: HIPERCOLESTEROLEMIA, MICRORNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOS, Bruna et al. Functional analysis of PCSK9 3'UTR variants and mRNA-miRNA interactions in patients with familial hypercholesterolemia. Epigenomics, v. 13, n. 10, p. 779–791, 2021Tradução . . Disponível em: https://doi.org/10.2217/epi-2020-0462. Acesso em: 16 nov. 2024.
APA
Los, B., Borges, J. B., Oliveira, V. F. de, Freitas, R. C. C. de, Hernandez, C. D., Bortolin, R. H., et al. (2021). Functional analysis of PCSK9 3'UTR variants and mRNA-miRNA interactions in patients with familial hypercholesterolemia. Epigenomics, 13( 10), 779–791. doi:10.2217/epi-2020-0462
NLM
Los B, Borges JB, Oliveira VF de, Freitas RCC de, Hernandez CD, Bortolin RH, Gonçalves RM, Faludi AA, Rodrigues AC, Bastos GM, Jannes CE, Pereira AC, Hirata RDC, Hirata MH. Functional analysis of PCSK9 3'UTR variants and mRNA-miRNA interactions in patients with familial hypercholesterolemia [Internet]. Epigenomics. 2021 ; 13( 10): 779–791.[citado 2024 nov. 16 ] Available from: https://doi.org/10.2217/epi-2020-0462
Vancouver
Los B, Borges JB, Oliveira VF de, Freitas RCC de, Hernandez CD, Bortolin RH, Gonçalves RM, Faludi AA, Rodrigues AC, Bastos GM, Jannes CE, Pereira AC, Hirata RDC, Hirata MH. Functional analysis of PCSK9 3'UTR variants and mRNA-miRNA interactions in patients with familial hypercholesterolemia [Internet]. Epigenomics. 2021 ; 13( 10): 779–791.[citado 2024 nov. 16 ] Available from: https://doi.org/10.2217/epi-2020-0462
Artigo de periodico
Functional analysis of PCSK9 3′UTR variants and mRNA–miRNA interactions in patients with familial hypercholesterolemia (2021)
Los, Bruna ; Borges, Jéssica Bassani ; Oliveira, Victor Fernandes de ; Freitas, Renata Carolina Costa de ; Hernandez, Carolina Dagli ; Bortolin, Raul Hernandes ; Gonçalves, Rodrigo M. ; Faludi, André A. ; Bastos, Gisele M. ; Jannes, Cinthia E. ; Pereira, Alexandre C. ; Rodrigues, Alice Cristina ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Source: Epigenomics. Unidades: ICB, FCF
Subjects: FARMACOLOGIA, HIPERCOLESTEROLEMIA, VARIAÇÃO GENÉTICA, MICRORNAS, ENVELHECIMENTO, RNA MENSAGEIRO, EPIGÊNESE GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOS, Bruna et al. Functional analysis of PCSK9 3′UTR variants and mRNA–miRNA interactions in patients with familial hypercholesterolemia. Epigenomics, v. 13, n. 10, p. 779–791, 2021Tradução . . Disponível em: https://doi.org/10.2217/epi-2020-0462. Acesso em: 16 nov. 2024.
APA
Los, B., Borges, J. B., Oliveira, V. F. de, Freitas, R. C. C. de, Hernandez, C. D., Bortolin, R. H., et al. (2021). Functional analysis of PCSK9 3′UTR variants and mRNA–miRNA interactions in patients with familial hypercholesterolemia. Epigenomics, 13( 10), 779–791. doi:10.2217/epi-2020-0462
NLM
Los B, Borges JB, Oliveira VF de, Freitas RCC de, Hernandez CD, Bortolin RH, Gonçalves RM, Faludi AA, Bastos GM, Jannes CE, Pereira AC, Rodrigues AC, Hirata RDC, Hirata MH. Functional analysis of PCSK9 3′UTR variants and mRNA–miRNA interactions in patients with familial hypercholesterolemia [Internet]. Epigenomics. 2021 ; 13( 10): 779–791.[citado 2024 nov. 16 ] Available from: https://doi.org/10.2217/epi-2020-0462
Vancouver
Los B, Borges JB, Oliveira VF de, Freitas RCC de, Hernandez CD, Bortolin RH, Gonçalves RM, Faludi AA, Bastos GM, Jannes CE, Pereira AC, Rodrigues AC, Hirata RDC, Hirata MH. Functional analysis of PCSK9 3′UTR variants and mRNA–miRNA interactions in patients with familial hypercholesterolemia [Internet]. Epigenomics. 2021 ; 13( 10): 779–791.[citado 2024 nov. 16 ] Available from: https://doi.org/10.2217/epi-2020-0462
Artigo de periodico
Atorvastatin attenuation of ABCB1 expression is mediated by microRNA miR-491-3p in Caco-2 cells (2016)
Rodrigues, Alice Cristina ; Neri, Elida Adalgisa; Veríssimo Filho, Sidney; Rebouças, Nancy Amaral; Hirata, Rosario Dominguez Crespo ; Yu, Ai Ming
Source: European Journal of Pharmaceutical Sciences. Unidades: ICB, FCF
Subjects: HIPERCOLESTEROLEMIA, EXPRESSÃO GÊNICA, RNA MENSAGEIRO, FISIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RODRIGUES, Alice Cristina et al. Atorvastatin attenuation of ABCB1 expression is mediated by microRNA miR-491-3p in Caco-2 cells. European Journal of Pharmaceutical Sciences, v. 93, p. 431-436, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2016.08.044. Acesso em: 16 nov. 2024.
APA
Rodrigues, A. C., Neri, E. A., Veríssimo Filho, S., Rebouças, N. A., Hirata, R. D. C., & Yu, A. M. (2016). Atorvastatin attenuation of ABCB1 expression is mediated by microRNA miR-491-3p in Caco-2 cells. European Journal of Pharmaceutical Sciences, 93, 431-436. doi:10.1016/j.ejps.2016.08.044
NLM
Rodrigues AC, Neri EA, Veríssimo Filho S, Rebouças NA, Hirata RDC, Yu AM. Atorvastatin attenuation of ABCB1 expression is mediated by microRNA miR-491-3p in Caco-2 cells [Internet]. European Journal of Pharmaceutical Sciences. 2016 ; 93 431-436.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.ejps.2016.08.044
Vancouver
Rodrigues AC, Neri EA, Veríssimo Filho S, Rebouças NA, Hirata RDC, Yu AM. Atorvastatin attenuation of ABCB1 expression is mediated by microRNA miR-491-3p in Caco-2 cells [Internet]. European Journal of Pharmaceutical Sciences. 2016 ; 93 431-436.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.ejps.2016.08.044
Artigo de periodico
Influence of the CYP3A4/5 genetic score and ABCB1 polymorphisms on tacrolimus exposure and renal function in Brazilian kidney transplant patients (2016)
Genvigir, F. D. V.; Salgado, P. C.; Felipe, C. R.; Luo, E. Y. F.; Alves, C.; Cerda, A.; Silva Junior, H. T.; Pestana, J. O. M.; Oliveira, N.; Rodrigues, Alice Cristina ; Doi, S. Q.; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Pharmacogenetics and Genomics. Unidades: ICB, FCF
Subjects: POLIMORFISMO, FÁRMACOS IMUNOSSUPRESSORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GENVIGIR, F. D. V. et al. Influence of the CYP3A4/5 genetic score and ABCB1 polymorphisms on tacrolimus exposure and renal function in Brazilian kidney transplant patients. Pharmacogenetics and Genomics, v. 26, n. 10, p. 462-472, 2016Tradução . . Disponível em: https://doi.org/10.1097/FPC.0000000000000237. Acesso em: 16 nov. 2024.
APA
Genvigir, F. D. V., Salgado, P. C., Felipe, C. R., Luo, E. Y. F., Alves, C., Cerda, A., et al. (2016). Influence of the CYP3A4/5 genetic score and ABCB1 polymorphisms on tacrolimus exposure and renal function in Brazilian kidney transplant patients. Pharmacogenetics and Genomics, 26( 10), 462-472. doi:10.1097/FPC.0000000000000237
NLM
Genvigir FDV, Salgado PC, Felipe CR, Luo EYF, Alves C, Cerda A, Silva Junior HT, Pestana JOM, Oliveira N, Rodrigues AC, Doi SQ, Hirata MH, Hirata RDC. Influence of the CYP3A4/5 genetic score and ABCB1 polymorphisms on tacrolimus exposure and renal function in Brazilian kidney transplant patients [Internet]. Pharmacogenetics and Genomics. 2016 ; 26( 10): 462-472.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1097/FPC.0000000000000237
Vancouver
Genvigir FDV, Salgado PC, Felipe CR, Luo EYF, Alves C, Cerda A, Silva Junior HT, Pestana JOM, Oliveira N, Rodrigues AC, Doi SQ, Hirata MH, Hirata RDC. Influence of the CYP3A4/5 genetic score and ABCB1 polymorphisms on tacrolimus exposure and renal function in Brazilian kidney transplant patients [Internet]. Pharmacogenetics and Genomics. 2016 ; 26( 10): 462-472.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1097/FPC.0000000000000237
Artigo de periodico
Modulation of adhesion molecules by cholesterol-lowering therapy in mononuclear cells from hypercholesterolemic patients (2015)
Cerda, Alvaro; Rodrigues, Alice Cristina ; Alves, Camila; Genvigir, Fabiana Dalla Vecchia; Fajardo, Cristina Moreno ; Dórea, Egidio Lima; Gusukuma, Maria Cecília; Pinto, Gelba Almeida; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Cardiovascular Therapeutics. Unidades: ICB, FCF, HU
Subjects: HIPERCOLESTEROLEMIA, COLESTEROL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CERDA, Alvaro et al. Modulation of adhesion molecules by cholesterol-lowering therapy in mononuclear cells from hypercholesterolemic patients. Cardiovascular Therapeutics, v. 33, n. 4, p. 168-176, 2015Tradução . . Disponível em: https://doi.org/10.1111/1755-5922.12126. Acesso em: 16 nov. 2024.
APA
Cerda, A., Rodrigues, A. C., Alves, C., Genvigir, F. D. V., Fajardo, C. M., Dórea, E. L., et al. (2015). Modulation of adhesion molecules by cholesterol-lowering therapy in mononuclear cells from hypercholesterolemic patients. Cardiovascular Therapeutics, 33( 4), 168-176. doi:10.1111/1755-5922.12126
NLM
Cerda A, Rodrigues AC, Alves C, Genvigir FDV, Fajardo CM, Dórea EL, Gusukuma MC, Pinto GA, Hirata MH, Hirata RDC. Modulation of adhesion molecules by cholesterol-lowering therapy in mononuclear cells from hypercholesterolemic patients [Internet]. Cardiovascular Therapeutics. 2015 ; 33( 4): 168-176.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1111/1755-5922.12126
Vancouver
Cerda A, Rodrigues AC, Alves C, Genvigir FDV, Fajardo CM, Dórea EL, Gusukuma MC, Pinto GA, Hirata MH, Hirata RDC. Modulation of adhesion molecules by cholesterol-lowering therapy in mononuclear cells from hypercholesterolemic patients [Internet]. Cardiovascular Therapeutics. 2015 ; 33( 4): 168-176.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1111/1755-5922.12126
Trabalho de evento-resumo periodico
Dowregulation of monocyte adhesion molecules by inhibition of synthesis and absorption of cholesterol (2014)
Cerda, Alvaro; Rodrigues, Alice Cristina ; Alves, Camila; Genvigir, Fabiana Dalla Vecchia; Fajardo, Cristina Moreno ; Dórea, Egidio Lima; Gusukuma, Maria Cecília; Pinto, Gelson de Almeida; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Atherosclerosis. Conference titles: European Atherosclerosis Society Congress (EAS). Unidades: ICB, FCF, HU
Subjects: COLESTEROL, MONÓCITOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CERDA, Alvaro et al. Dowregulation of monocyte adhesion molecules by inhibition of synthesis and absorption of cholesterol. Atherosclerosis. Clare: Instituto de Ciências Biomédicas, Universidade de São Paulo. . Acesso em: 16 nov. 2024. , 2014
APA
Cerda, A., Rodrigues, A. C., Alves, C., Genvigir, F. D. V., Fajardo, C. M., Dórea, E. L., et al. (2014). Dowregulation of monocyte adhesion molecules by inhibition of synthesis and absorption of cholesterol. Atherosclerosis. Clare: Instituto de Ciências Biomédicas, Universidade de São Paulo.
NLM
Cerda A, Rodrigues AC, Alves C, Genvigir FDV, Fajardo CM, Dórea EL, Gusukuma MC, Pinto G de A, Hirata MH, Hirata RDC. Dowregulation of monocyte adhesion molecules by inhibition of synthesis and absorption of cholesterol. Atherosclerosis. 2014 ; 235( 2): e255 res. EAS-0490.[citado 2024 nov. 16 ]
Vancouver
Cerda A, Rodrigues AC, Alves C, Genvigir FDV, Fajardo CM, Dórea EL, Gusukuma MC, Pinto G de A, Hirata MH, Hirata RDC. Dowregulation of monocyte adhesion molecules by inhibition of synthesis and absorption of cholesterol. Atherosclerosis. 2014 ; 235( 2): e255 res. EAS-0490.[citado 2024 nov. 16 ]
Artigo de periodico
Influence of SLCO1B1 and SLCO2B1 polymorphisms on tacrolimus pharmacokinetics and clinical response (2014)
Alves, Camila; Felipe, Claudia Rosso; Nishikawa, Alvaro Mitsunori; Salgado, Patricia de Cássia; Fajardo, Cristina Moreno ; Silva Junior, Helio Tedesco; Pestana, Jose Osmar Medina; Zetchaku, Denize; Spinelli, Glaucio; Oliveira, Nagilla; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo ; Rodrigues, Alice Cristina
Source: Journal Pharmacogenomics Pharmacoproteomics. Unidades: FCF, ICB
Subjects: POLIMORFISMO, FARMACOCINÉTICA, TRANSPLANTE DE RIM
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALVES, Camila et al. Influence of SLCO1B1 and SLCO2B1 polymorphisms on tacrolimus pharmacokinetics and clinical response. Journal Pharmacogenomics Pharmacoproteomics, v. 5, n. 3, p. 1-16 art. 1000134, 2014Tradução . . Disponível em: https://doi.org/10.4172/2153-0645.1000134. Acesso em: 16 nov. 2024.
APA
Alves, C., Felipe, C. R., Nishikawa, A. M., Salgado, P. de C., Fajardo, C. M., Silva Junior, H. T., et al. (2014). Influence of SLCO1B1 and SLCO2B1 polymorphisms on tacrolimus pharmacokinetics and clinical response. Journal Pharmacogenomics Pharmacoproteomics, 5( 3), 1-16 art. 1000134. doi:10.4172/2153-0645.1000134
NLM
Alves C, Felipe CR, Nishikawa AM, Salgado P de C, Fajardo CM, Silva Junior HT, Pestana JOM, Zetchaku D, Spinelli G, Oliveira N, Hirata MH, Hirata RDC, Rodrigues AC. Influence of SLCO1B1 and SLCO2B1 polymorphisms on tacrolimus pharmacokinetics and clinical response [Internet]. Journal Pharmacogenomics Pharmacoproteomics. 2014 ; 5( 3): 1-16 art. 1000134.[citado 2024 nov. 16 ] Available from: https://doi.org/10.4172/2153-0645.1000134
Vancouver
Alves C, Felipe CR, Nishikawa AM, Salgado P de C, Fajardo CM, Silva Junior HT, Pestana JOM, Zetchaku D, Spinelli G, Oliveira N, Hirata MH, Hirata RDC, Rodrigues AC. Influence of SLCO1B1 and SLCO2B1 polymorphisms on tacrolimus pharmacokinetics and clinical response [Internet]. Journal Pharmacogenomics Pharmacoproteomics. 2014 ; 5( 3): 1-16 art. 1000134.[citado 2024 nov. 16 ] Available from: https://doi.org/10.4172/2153-0645.1000134
Artigo de periodico
Inﬂuence of PCSK9 polymorphisms on plasma lipids and response to atorvastatin treatment in Brazilian subjects (2014)
Anderson, Jacqueline M.; Cerda, Alvaro ; Hirata, Mario Hiroyuki ; Rodrigues, Alice Cristina ; Dórea, Egidio Lima; Bernik, Marcia Martins Silveira; Bertolami, Marcelo Chiara ; Faludi, André Arpad; Hirata, Rosario Dominguez Crespo
Source: Journal of Clinical Lipidology. Unidades: FCF, ICB, HU
Subjects: POLIMORFISMO, COLESTEROL, FARMACOLOGIA, LIPÍDEOS, NUCLEOTÍDEOS, FARMACOGENÉTICA, LIPOPROTEÍNAS LDL, REAÇÃO EM CADEIA POR POLIMERASE, PLASMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANDERSON, Jacqueline M. et al. Inﬂuence of PCSK9 polymorphisms on plasma lipids and response to atorvastatin treatment in Brazilian subjects. Journal of Clinical Lipidology, v. 8, n. 3, p. 256-264, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.jacl.2014.02.008. Acesso em: 16 nov. 2024.
APA
Anderson, J. M., Cerda, A., Hirata, M. H., Rodrigues, A. C., Dórea, E. L., Bernik, M. M. S., et al. (2014). Inﬂuence of PCSK9 polymorphisms on plasma lipids and response to atorvastatin treatment in Brazilian subjects. Journal of Clinical Lipidology, 8( 3), 256-264. doi:10.1016/j.jacl.2014.02.008
NLM
Anderson JM, Cerda A, Hirata MH, Rodrigues AC, Dórea EL, Bernik MMS, Bertolami MC, Faludi AA, Hirata RDC. Inﬂuence of PCSK9 polymorphisms on plasma lipids and response to atorvastatin treatment in Brazilian subjects [Internet]. Journal of Clinical Lipidology. 2014 ; 8( 3): 256-264.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.jacl.2014.02.008
Vancouver
Anderson JM, Cerda A, Hirata MH, Rodrigues AC, Dórea EL, Bernik MMS, Bertolami MC, Faludi AA, Hirata RDC. Inﬂuence of PCSK9 polymorphisms on plasma lipids and response to atorvastatin treatment in Brazilian subjects [Internet]. Journal of Clinical Lipidology. 2014 ; 8( 3): 256-264.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.jacl.2014.02.008

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Source title

Indexado em

Non normalized affiliation